Correspondence
PIP Silicone Gel Breast Implants: Letter from CMO
This letter from Professor Sally Davies, Chief Medical Officer, explains about recommendation from the Medicines and Healthcare Products Regulatory Agency on PIP breast implants.
Documents
PDF, 37.7 KB, 2 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
This letter from Professor Sally Davies, Chief Medical Officer, explains about recommendation from the Medicines and Healthcare Products Regulatory Agency on PIP breast implants.
Updates to this page
Published 23 December 2011